Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
24 25 Search
2019
Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis
Journal of Translational Medicine
2019
Synergistic Effects of Interferon-γ and Vitamin D3 Signaling in Induction of ILT-3highPDL-1high Tolerogenic Dendritic Cells
Frontiers in Immunology
2019
Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
Frontiers in Immunology
2019
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective
Frontiers in Immunology
2019
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Proceedings of the National Academy of Sciences
2019
Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets
Frontiers in Immunology
2019
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
Frontiers in Immunology
2018
Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
Immunology
2018
Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy
Cytotherapy
2018
Exploring the Immunomodulatory Moonlighting Activities of Acute Phase Proteins for Tolerogenic Dendritic Cell Generation
Frontiers in Immunology
2018
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Frontiers in Immunology
2018
Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice
Frontiers in Immunology
2018
Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry
Frontiers in Immunology
2018
European Reflections on New Indications for Extracorporeal Photopheresis in Solid Organ Transplantation
Transplantation
2018
Trichinella spiralis Excretory–Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4
Frontiers in Immunology
2017
Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials
Frontiers in Immunology
2017
Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment
Frontiers in Immunology
2017
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+T cells partly via transforming growth factor-β1
Clinical & Experimental Immunology
2017
Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity
Frontiers in Immunology
2017
Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses
Frontiers in Immunology
2017
Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease
Frontiers in Immunology
2017
Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response
Frontiers in Immunology
2017
MITAP-compliant characterization of human regulatory macrophages
Transplant International
2016
Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features
Frontiers in Immunology
Additional cited-by details will be shown when available from Crossref